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The former US Secretary of Defense,
Donald Rumsfeld, once famously divided
our areas of understanding into three
categories: ‘‘known knowns … things we
know we know’’, ‘‘known unknowns …
[things we] know we … do not know’’, and
‘‘unknown unknowns—the ones we don’t
know we don’t know’’ [1]. In HIV immu-
nity, the role of CD8+ cytotoxic T lympho-
cytes (CTLs) in controlling virus has been
thought to be ‘‘known’’ for over two
decades. The recognition of viral peptides
by CD8+ T cells was initially demonstrated
by showing that CTLs could lyse chromi-
um-labeled target cells presenting viral
epitopes [2]. Multiple lines of evidence have
subsequently supported the important role
for CTLs in controlling HIV replication
[3,4]. However, most of these studies have
not explicitly examined the mechanisms by
which viral control is achieved. Because of
the name (‘‘cytotoxic’’) and the early assays
for detection (measuring cytolysis using
chromium release in vitro), it is usually
assumed that CD8+ Tc e l l sc o n t r o lH I V
infection by killing HIV-infected cells.
Indeed, the use of the terms CD8+ T
lymphocyte and cytotoxic T lymphocyte
have become almost interchangeable in
HIV. Thus, the mechanism of CTL control
of infection through the cytolysis of infected
cells has fallen into the category of a
‘‘known known’’.
Two papers in this issue of PLoS
Pathogens present a major challenge to the
assumption that CD8+ T cells kill HIV-
infected cells [5,6]. Using very similar
methodology, Klatt et al. and Wong et al.
used an approach of depleting CD8+ T
cells during simian immunodeficiency
virus (SIV) infection of macaques to study
the mechanisms of CD8+ T cell control of
virus. What makes their studies different
from previous studies of CD8+ T cell
depletion is that they also treated animals
with anti-retroviral therapy (ART) after
CD8+ T cell depletion. Because ART
blocks subsequent rounds of viral infec-
tion, it has been used extensively over the
last decade to study the turnover of HIV-
infected cells [7,8]. Combining CD8
depletion and ART treatment allowed
the two groups to study the death rate of
SIV-infected cells in the presence and
absence of CD8+ T cells. Remarkably, the
groups found no difference in the decay
rate of virus in CD8-depleted compared to
control animals. This indicates that CD8+
T cells had no significant impact on the
death rate of infected cells, suggesting that
a high death rate is an intrinsic property of
infected cells. Since CD8+ T cells have a
clear role in viral control, they must act
via some mechanism other than lysis of
infected cells.
On the surface, we could simply accept
that CD8+ T cell control of HIV infection
acts via non-cytolytic mechanisms such as
the production of cytokines and/or chemo-
kines, and make that our new credo. Such a
shift in beliefs would be supported by the
demonstration that the ability of CD8+
T cells to produce multiple cytokines is
associated with good viral control in HIV,
suggesting an important role for cytokines
[9,10]. However, it is difficult to reconcile
the results of the Klatt and Wong papers
with other recent in vivo and in vitro results
(see Table 1). First amongst these are
studies of CD8+ T cell depletion in acute
SIV infection [3,11]. These studies dem-
onstrate that in the absence of CD8+ T
cells, the virus level rises to its ‘‘normal’’
peak in acute infection, but then does not
decline from the peak for a prolonged
period. The simplest interpretation of this
result is that, in the absence of CD8+ T
cells, the peak number of infected cells does
not decline, but remains constant because
these cells are not dying. However, two
other observations make this unlikely: First,
the increased loss of CD4+ T cells in CD8-
depleted animals indicates that many cells
are dying. Second, the Klatt and Wong
results show that infected cells die at the
same rate independent of the presence of
CD8+ T cells in chronic infection, so why
would things be so different in primary
infection? How can viral load stay so high
in CD8-depleted animals in acute infection
if infected cells are dying at the same rate?
One explanation would be that CD8+ T
celldepletion leads to activationof CD4+ T
cells; since SIV preferentially infects acti-
vated cells, the infected CD4+ T cells
are dying, but these dying cells are being
replaced because of the high level of CD4+
T cell activation. However, a recent study
of CD8+ T cell depletion in acute SIV
infection has excluded this possibility, by
showing that CD4+ T cell activation is
neither necessary nor sufficient to produce
the prolonged high viral loads observed in
vivo [11].
A non-cytolytic mechanism of CD8+ T
cell control in vivo is also difficult to
reconcile with in vitro results directly
demonstrating CD8+ T cell lysis [2,12].
Early studies of in vitro lysis relied on
pulsing target cells with HIV peptides, or
infecting cells with vaccinia virus bearing
HIV proteins [2]. These experiments may
not reflect the normal levels of peptide-
MHC present on HIV-infected cells, both
because they may involve unphysiologi-
cally high doses of peptide, and because
HIV Nef is known to down-regulate MHC
class I expression in infected cells. How-
ever, recent studies have demonstrated the
recognition and lysis of HIV-infected
primary target cells in vitro, presumably
bearing physiological levels of peptide, and
suffering any effects of Nef and other
proteins on antigen presentation [12].
Notably, these studies required prior
activation of the CD8+ T cells to demon-
strate high levels of killing, but still suggest
a role for direct killing of infected cells. A
compromise between the cytolytic and
non-cytolytic camps is the idea that
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period’’ before they start to produce virus
[13,14]. However, this still fails to explain
all of the experimental observations.
The Klatt and Wong papers provide a
direct challenge to the assumption that
CD8+ T cell cytolysis of infected cells is
the mechanism of viral control in HIV.
However, it is difficult to reconcile the
combination of in vivo and in vitro results
investigating CD8+ T cell activity in HIV.
Given the enormous effort invested in the
development of HIV vaccines specifically
directed at inducing CD8+ T cell respons-
es, it is somewhat disconcerting to admit
that CD8+ T cell function in HIV remains
a ‘‘known unknown’’.
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